Sanofi and GSK signed an agreement with the Government of Canada to supply 72 million doses of COVID-19 vaccine. At present, the research is in 1/2 phase. Companies are expecting the first results from September 3 to the end of December 2020. If there is enough data to apply for a license, mass production of the vaccine will begin in the first half of 2021.
Sanofi and GSK signed an agreement with the Government of Canada to supply 72 million doses of COVID-19 vaccine. At present, the research is in 1/2 phase. Companies are expecting the first results from September 3 to the end of December 2020. If there is enough data to apply for a license, mass production of the vaccine will begin in the first half of 2021. 
www2.trustnet.com
English (US) 